These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 7515227)

  • 41. Platelet aggregating response to platelet activating factor participates in activation of the 12-lipoxygenase pathway in platelets from rabbits.
    Michibayashi T
    Int Angiol; 2002 Sep; 21(3):260-7. PubMed ID: 12384648
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evidence for a direct effect on vascular permeability of platelet-activating factor induced hemoconcentration in the guinea pig.
    Handley DA; Lee ML; Saunders RN
    Thromb Haemost; 1985 Dec; 54(4):756-9. PubMed ID: 4089809
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Regulatory role of protein tyrosine phosphorylation in platelet activating factor-induced signal transduction in platelets.
    Zeng S; Yi FX; Guo ZG
    Zhongguo Yao Li Xue Bao; 1999 Feb; 20(2):157-61. PubMed ID: 10437164
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The antagonistic effects of khellactones on platelet-activating factor, histamine, and leukotriene D4.
    Aida Y; Kasama T; Takeuchi N; Tobinaga S
    Chem Pharm Bull (Tokyo); 1995 May; 43(5):859-67. PubMed ID: 7553972
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Platelet-activating factor (PAF) inhibitory profile of KO-286011 on blood platelets in vitro and in vivo.
    Ostermann G; Hofmann B; Kertscher HP; Till U
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Dec; 342(6):713-8. PubMed ID: 2096302
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Development of a sensitive and specific 14C-serotonin release assay for platelet-activating factor (PAF) in human neutrophils.
    Müller S; Nigam S
    J Lipid Mediat; 1990; 2(6):329-41. PubMed ID: 2133275
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antibodies to platelet-activating factor (PAF) inhibit PAF-induced platelet aggregation.
    Smal MA; Cooney SJ; Baldo BA
    J Lipid Mediat; 1991 Nov; 4(3):333-41. PubMed ID: 1764578
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of platelet-activating factor (PAF) in platelet accumulation in rabbit skin: effect of the novel long-acting PAF antagonist, UK-74,505.
    Pons F; Rossi AG; Norman KE; Williams TJ; Nourshargh S
    Br J Pharmacol; 1993 May; 109(1):234-42. PubMed ID: 8495241
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The thrombocyte-activation factor and endotoxin-induced thrombocyte activation].
    Lomazova KD; Poliakova AM; Astrina OS; Tsukerman DB
    Biull Eksp Biol Med; 1989 May; 107(5):538-40. PubMed ID: 2500157
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Isolation of a phospholipid inhibitor of platelet activating factor-induced activity from perfused rat liver: identification as phosphatidylglycerol.
    Lekka M; Tokumura A; Tsuji H; Hanahan DJ
    Arch Biochem Biophys; 1993 May; 302(2):380-4. PubMed ID: 8489242
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibitory effect of the Korean herbal medicine, Dae-Jo-Whan, on platelet-activating factor-induced platelet aggregation.
    Chang GT; Kang SK; Kim JH; Chung KH; Chang YC; Kim CH
    J Ethnopharmacol; 2005 Dec; 102(3):430-9. PubMed ID: 16125889
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MK 287: a potent, specific, and orally active receptor antagonist of platelet-activating factor.
    Hwang SB; Lam MH; Szalkowski DM; MacIntyre DE; Bach TJ; Luell S; Meuer R; Sahoo SP; Alberts AW; Chabala JC
    J Lipid Mediat; 1993 Jun; 7(2):115-34. PubMed ID: 8400114
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CIS-19, a novel platelet activating factor receptor antagonist: in vitro and in vivo studies.
    Ko FN; Yu SM; Chen IS; Ishii H; Chang YL; Huang TF; Teng CM
    Biochim Biophys Acta; 1993 Jan; 1175(2):225-31. PubMed ID: 8380343
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Effects of platelet activating factor on release of thromboxane B2 from human granulocytes and platelets].
    Imai T; Horikoshi S; Kurokawa M; Idaira K; Mita S; Adachi M; Okamoto M
    Arerugi; 1994 Jul; 43(7):809-14. PubMed ID: 7980021
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of CV-3988, an antagonist of platelet-activating factor (PAF), on washed rabbit platelets.
    Cox CP
    Thromb Res; 1986 Jan; 41(2):211-22. PubMed ID: 2421432
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of MK-447 on thrombin-induced aggregation, secretion of ATP, and [Ca2+]i mobilization in rabbit platelets.
    Li BY; Bai Y; Li GZ; Li WH; Katori M
    Zhongguo Yao Li Xue Bao; 1995 Mar; 16(2):108-13. PubMed ID: 7597907
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Influence of platelet activating factor antagonists on the protamine sulphate stimulated release of histamine from peritoneal mast cells of rats in vitro.
    Lohde C; Bahr T; Labes D; Grupe R
    Arzneimittelforschung; 1992 Jan; 42(1):27-31. PubMed ID: 1375025
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of 5-HT released from platelets on thrombin-induced aggregation and ATP release in rabbit platelets in vitro.
    Li BY; Li WH
    Zhongguo Yao Li Xue Bao; 1998 Jul; 19(4):383-6. PubMed ID: 10375791
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vitro inhibitory effect of SR 27417, a potent platelet-activating factor (PAF) receptor antagonist, on the PAF-induced bovine platelet aggregation.
    Bastos da Silva M; Delaunois A; Gustin P; Godeau JM; Lekeux P
    Vet Res; 2000; 31(2):267-72. PubMed ID: 10779205
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Spasmogenic properties of platelet-activating factor: evidence for a direct mechanism in the contractile response of pulmonary tissues.
    Stimler NP; O'Flaherty JT
    Am J Pathol; 1983 Oct; 113(1):75-84. PubMed ID: 6624879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.